查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1848380

2032 年肠道健康和微生物组补充剂市场预测：按产品类型、成分、配方、分销管道、应用、最终用户和地区进行的全球分析

Gut Health and Microbiome Supplement Market Forecasts to 2032 - Global Analysis By Product Type, Ingredient, Formulation, Distribution Channel, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球肠道健康和微生物组补充剂市场预计在 2025 年达到 144 亿美元，到 2032 年将达到 261 亿美元，预测期内的复合年增长率为 8.8%。

肠道健康和微生物组市场专注于益生菌、益生元、合益素、后生元以及旨在透过肠道微生物组支持消化健康、免疫功能和整体健康的定製配方。越来越多的科学证据显示微生物组平衡与健康结果息息相关，对预防性医疗保健的兴趣日益浓厚，以及消费者对个人化营养的需求推动了市场的成长。菌株特异性研究、递送系统和临床检验的进展也增强了可信度。

根据国际食品资讯委员会（IFIC）2022年的一项调查，四分之一的美国认为肠道健康是他们整体健康中最重要的方面，这表明消费者对相关产品的认知度和需求很高。

对天然和植物性补充剂的需求不断增长

这一市场很大程度上是由消费者对天然和植物来源健康解决方案的强烈偏好所驱动。现今的消费者对合成成分越来越谨慎，并寻求标籤更干净、来源更明确的产品。越来越多的研究检验了植物成分以及天然来源的益生菌和益生元的有效性，进一步强化了这个趋势。因此，製造商正在大力投资开发非基因改造、有机和永续的植物来源补充剂，这些补充剂直接符合注重健康的消费者的道德规范，并透过有针对性的产品创新和行销来推动市场扩张。

高级补充品配方高成本

阻碍更广泛市场渗透的一个主要因素是高级微生物组补充剂的高价格。这些产品通常包含经过临床研究的取得专利的菌株、先进的给药系统（例如延迟释放胶囊）以及严格的第三方效力和纯度测试。相关的研发和品质保证成本高昂，并转嫁给消费者。这给了很大一部分潜在买家（尤其是在价格敏感的新兴市场）造成了巨大的价格壁垒，从而抑制了整体市场的成长。

将补充剂与机能性食品和饮料结合

益生菌果汁、益生元能量棒和发酵饮料等强化产品提供了便利、个人化的摄取选择，吸引了那些不喜欢吞服药丸的人。这项策略有效地将市场从传统的补充剂使用者拓展到更广泛的注重健康的消费者群体。此外，鼓励每日坚持并持续支持微生物组，为补充剂製造商与食品饮料公司之间的跨行业合作提供了重要机会。

潜在的副作用和不良反应

该市场面临潜在副作用的持续威胁，包括初期腹胀、胀气以及免疫力缺乏人群中更严重的副作用。一旦发生这些副作用，可能会导致消费者负面评价和产品退货，严重的情况甚至会面临法律挑战和监管审查。此类事件会迅速削弱消费者对品牌或更广泛的补充剂类别的信任。保持标籤透明、剂量和使用说明清晰，并投入资金进行消费者教育，对于减轻这些威胁并维护市场信誉至关重要。

COVID-19的影响：

疫情催生了肠道健康补充品市场。广泛的研究表明，健康的肠道菌群与强大的免疫功能息息相关，这导致益生菌和益生元的需求激增。然而，由于全球供应链和原料采购中断导致暂时供不应求和生产延迟，这一增长最初有所放缓。疫情的持续影响提高了消费者对主动健康管理的意识，市场最终也做出了调整。

益生菌市场预计将成为预测期内最大的市场

益生菌类别预计将占据最大的市场份额，这得益于其扎实的科学检验和消费者的深度熟悉。数十年的临床研究已确凿证明，特定的益生菌菌株有益于消化器官系统健康、免疫支持，甚至心理健康，这使得消费者和医疗保健专业人士对这些产品拥有高度的信任。此外，益生菌是微生物组领域最成熟、定义最明确的类别，拥有广泛的市售选择。这种稳固的市场地位和经过验证的有效性，使益生菌成为大多数寻求肠道健康解决方案的消费者的预设和最值得信赖的选择。

预计在预测期内，液体和软糖部分将以最高的复合年增长率成长。

预计液体和软糖细分市场将实现最高成长率，这得益于消费者偏好从根本上转向美味便捷的补充剂形式。这些给药方式对关键族群尤其具有吸引力，包括儿童、老年人以及吞嚥传统片剂和胶囊有困难的人。此外，软糖的宜人口感和易咀嚼的特性提高了每日补充剂摄取的依从性。市场细分正利用这一趋势，推出无糖、天然香料和高活性配方等创新产品，使该市场成为最具活力、成长最快的细分市场之一。

占比最大的地区：

预计北美将在预测期内占据最大的市场份额。这一主导地位可归因于几个关键因素，包括消费者健康意识的增强、高可支配收入以及完善的膳食补充剂零售和电商基础。该地区拥有成熟的消费者群体，他们对肠道健康与免疫系统之间的联繫瞭如指掌，推动了持续的需求。此外，主要市场参与者的存在、积极的营销策略以及能够增强消费者信心的强大法律规范，巩固了北美在市场上的主导地位。

复合年增长率最高的地区：

预计亚太地区在预测期内的复合年增长率最高。这一爆炸性增长的驱动力在于快速壮大的中等收入阶层，他们可支配收入不断增加，健康意识不断增强，预防性保健意识也日益增强。都市化和西方健康趋势的影响使消费者更容易接受膳食补充剂。此外，中国和印度等国家拥有庞大的人口基数，蕴藏着巨大的尚未开发的市场机会。本土製造商也积极开发符合当地需求且价格实惠的产品，形成了一个充满活力且快速成长的市场格局。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业进行基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 二手研究资料
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球肠道健康和微生物组补充剂市场（按产品类型）

  • 益生菌
  • 益生元
  • 合益素
  • 后生元
  • 酵素
  • 其他产品类型

6. 全球肠道健康和微生物组补充剂市场（按成分）

  • 细菌
  • 酵母菌
  • 纤维

7. 全球肠道健康和微生物组补充剂市场（按配方）

  • 胶囊和片剂
  • 粉末小袋
  • 液体和软糖

8. 全球肠道健康和微生物组补充剂市场（按分销管道）

  • 大卖场/超级市场
  • 药局和药局
  • 网上零售/电子商务
  • 专卖店

9. 全球肠道健康和微生物组补充剂市场（按应用）

  • 消化器官系统健康
  • 免疫支持
  • 体重管理
  • 心理和认知健康
  • 其他用途

10. 全球肠道健康和微生物组补充剂市场（按最终用户）

  • 成人
  • 孩子
  • 老年人

11. 全球肠道健康和微生物组补充剂市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章：企业概况

  • Nestle Health Science
  • Bayer AG
  • Church & Dwight Co., Inc.
  • NOW Health Group
  • Danone SA
  • Procter & Gamble Co.
  • BioGaia AB
  • Dr. Willmar Schwabe GmbH & Co. KG
  • Amway Corporation
  • Reckitt Benckiser Group plc
  • DSM-Firmenich
  • Yakult Honsha Co., Ltd.
  • Seed Health, Inc.
  • Pendulum Therapeutics
  • BIOHM Health
  • Seres Therapeutics, Inc.
  • Ferring BV
  • BiomeBank
  • International Flavors & Fragrances Inc.（IFF）
  • OptiBiotix Health Plc
Product Code: SMRC31558

According to Stratistics MRC, the Global Gut Health and Microbiome Supplement Market is accounted for $14.4 billion in 2025 and is expected to reach $26.1 billion by 2032 growing at a CAGR of 8.8% during the forecast period. Gut health and microbiome market focuses on probiotics, prebiotics, synbiotics, postbiotics, and tailored formulations aimed at supporting digestive health, immune function, and overall wellbeing via the gut microbiome. Growth is driven by expanding scientific evidence linking microbiome balance to health outcomes, rising preventive healthcare interest, and consumer demand for personalized nutrition. Advances in strain-specific research, delivery systems, and clinical validation enhance credibility.

According to a 2022 survey by the International Food Information Council (IFIC), one in four Americans considered gut health to be the most important aspect of their overall health, indicating high consumer awareness and demand for related products.

Market Dynamics:

Driver:

Growing demand for natural and plant-based supplements

The market is significantly propelled by a pronounced consumer pivot towards natural and plant-based wellness solutions. Modern consumers are increasingly wary of synthetic ingredients, seeking cleaner labels and products derived from recognizable sources. This trend is amplified by a growing body of research validating the efficacy of botanicals and natural strains of probiotics and prebiotics. Consequently, manufacturers are heavily investing in developing supplements from non-GMO, organic, and sustainable plant sources, directly aligning with this health-conscious consumer ethos and driving market expansion through targeted product innovation and marketing.

Restraint:

High cost of advanced supplement formulations

A primary factor limiting broader market penetration is the elevated price point of advanced microbiome supplements. These products often incorporate clinically studied, patented bacterial strains, sophisticated delivery systems like delayed-release capsules, and rigorous third-party testing for potency and purity. The associated research, development, and quality assurance costs are substantial and are passed on to the consumer. This creates a significant price barrier for a large segment of potential buyers, particularly in price-sensitive emerging markets, thereby restricting the overall market growth.

Opportunity:

Integration of supplements with functional foods and beverages

The fortification of products like probiotic juices, prebiotic snack bars, and fermented drinks offers a convenient and discrete consumption method, appealing to those who dislike swallowing pills. This strategy effectively expands the market reach beyond traditional supplement users to a broader health-aware demographic. Moreover, it encourages daily adherence and allows for continuous microbiome support, presenting a significant opportunity for cross-industry collaboration between supplement manufacturers and food and beverage companies.

Threat:

Potential side effects and adverse reactions

The market faces a persistent threat from the potential for side effects, such as initial bloating, gas, or more serious adverse reactions in immunocompromised individuals. These incidents, when they occur, can lead to negative consumer reviews, product returns, and in severe cases, legal challenges or regulatory scrutiny. Such events can rapidly erode consumer trust in a brand or even the broader supplement category. Maintaining transparent labeling, clear dosage instructions, and investing in consumer education is crucial to mitigate this threat and uphold the market's credibility.

Covid-19 Impact:

The pandemic served as a catalyst for the gut health supplement market, as consumers became intensely focused on bolstering their innate immunity. Widespread research linking a healthy gut microbiome to robust immune function drove a surge in demand for probiotics and prebiotics. However, this growth was tempered by initial disruptions in the global supply chain and raw material sourcing, leading to temporary shortages and production delays. The market ultimately adapted, with the pandemic leaving a lasting legacy of heightened consumer awareness about proactive health management.

The probiotics segment is expected to be the largest during the forecast period

The probiotics segment is projected to account for the largest market share, a dominance rooted in strong scientific validation and deep-rooted consumer familiarity. Decades of clinical research have conclusively established the benefits of specific probiotic strains for digestive wellness, immune support, and even mental health, giving consumers and healthcare professionals high confidence in these products. Furthermore, probiotics represent the most mature and well-defined category within the microbiome space, with an extensive range of over-the-counter options available. This established market presence and proven efficacy make probiotics the default and most trusted choice for a majority of consumers seeking gut health solutions.

The liquids & gummies segment is expected to have the highest CAGR during the forecast period

The liquids and gummies segment is anticipated to register the highest growth rate, driven by a fundamental shift in consumer preference towards enjoyable and convenient supplement formats. These delivery systems are particularly appealing to key demographics such as children, seniors, and anyone who has difficulty swallowing traditional pills or capsules. Additionally, the pleasant taste and chewable nature of gummies improve adherence to daily supplement regimens. Manufacturers are capitalizing on this trend by innovating with sugar-free options, natural flavors, and high-potency formulations, making this the most dynamic and rapidly expanding segment in the market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. This leadership position is attributed to several key factors, including high consumer health awareness, strong disposable income, and a well-established retail and e-commerce infrastructure for dietary supplements. The region has a mature consumer base that is well-informed about the gut-health-immune-system connection, driving consistent demand. Moreover, the presence of major market players, aggressive marketing strategies, and a robust regulatory framework that inspires consumer confidence collectively solidify North America's dominant position in the market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This explosive growth is fueled by a rapidly expanding middle class with increasing disposable income, rising health consciousness, and growing awareness of preventive healthcare. Urbanization and the influence of Western health trends are making consumers more receptive to dietary supplements. Furthermore, the vast population base in countries like China and India presents an immense, yet under-penetrated, market opportunity. Local manufacturers are also actively developing affordable products tailored to regional preferences, creating a highly dynamic and fast-growing market landscape.

Key players in the market

Some of the key players in Gut Health and Microbiome Supplement Market include Nestle Health Science, Bayer AG, Church & Dwight Co., Inc., NOW Health Group, Danone S.A., Procter & Gamble Co., BioGaia AB, Dr. Willmar Schwabe GmbH & Co. KG, Amway Corporation, Reckitt Benckiser Group plc, DSM-Firmenich, Yakult Honsha Co., Ltd., Seed Health, Inc., Pendulum Therapeutics, BIOHM Health, Seres Therapeutics, Inc., Ferring B.V., BiomeBank, International Flavors & Fragrances Inc. (IFF), and OptiBiotix Health Plc.

Key Developments:

In June 2025, Danone announces the acquisition of The Akkermansia Company (TAC), a Belgian company with nearly 20 years of history and science, specializing in biotics. Expanding deeper into gut health is a key facet of Danone's Renew strategy, as it doubles down on science and innovation, and as consumer interest in healthy products continues to rise.

In April 2025, DSM-Firmenich launched its Healthy Longevity innovation platform at Vitafoods Europe 2025, focusing on gut health and healthy aging.

In March 2024, Garden of Life, a Nestle Health Science brand, launched Non-GMO and USDA Organic Certified probiotics within its sports nutrition portfolio promoting digestive health.

Product Types Covered:

  • Probiotics
  • Prebiotics
  • Synbiotics
  • Postbiotics
  • Enzymes
  • Other Product Types

Ingredients Covered:

  • Bacteria
  • Yeast
  • Fibers

Formulations Covered:

  • Capsules & Tablets
  • Powder & Sachets
  • Liquids & Gummies

Distribution Channels Covered:

  • Hypermarkets/Supermarkets
  • Pharmacies & Drug Stores
  • Online Retail/E-commerce
  • Specialty Stores

Applications Covered:

  • Digestive Health
  • Immune Support
  • Weight Management
  • Mental & Cognitive Health
  • Other Applications

End Users Covered:

  • Adults
  • Children
  • Elderly

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gut Health and Microbiome Supplement Market, By Product Type

  • 5.1 Introduction
  • 5.2 Probiotics
  • 5.3 Prebiotics
  • 5.4 Synbiotics
  • 5.5 Postbiotics
  • 5.6 Enzymes
  • 5.7 Other Product Types

6 Global Gut Health and Microbiome Supplement Market, By Ingredient

  • 6.1 Introduction
  • 6.2 Bacteria
  • 6.3 Yeast
  • 6.4 Fibers

7 Global Gut Health and Microbiome Supplement Market, By Formulation

  • 7.1 Introduction
  • 7.2 Capsules & Tablets
  • 7.3 Powder & Sachets
  • 7.4 Liquids & Gummies

8 Global Gut Health and Microbiome Supplement Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Hypermarkets/Supermarkets
  • 8.3 Pharmacies & Drug Stores
  • 8.4 Online Retail/E-commerce
  • 8.5 Specialty Stores

9 Global Gut Health and Microbiome Supplement Market, By Application

  • 9.1 Introduction
  • 9.2 Digestive Health
  • 9.3 Immune Support
  • 9.4 Weight Management
  • 9.5 Mental & Cognitive Health
  • 9.6 Other Applications

10 Global Gut Health and Microbiome Supplement Market, By End User

  • 10.1 Introduction
  • 10.2 Adults
  • 10.3 Children
  • 10.4 Elderly

11 Global Gut Health and Microbiome Supplement Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Nestle Health Science
  • 13.2 Bayer AG
  • 13.3 Church & Dwight Co., Inc.
  • 13.4 NOW Health Group
  • 13.5 Danone S.A.
  • 13.6 Procter & Gamble Co.
  • 13.7 BioGaia AB
  • 13.8 Dr. Willmar Schwabe GmbH & Co. KG
  • 13.9 Amway Corporation
  • 13.10 Reckitt Benckiser Group plc
  • 13.11 DSM-Firmenich
  • 13.12 Yakult Honsha Co., Ltd.
  • 13.13 Seed Health, Inc.
  • 13.14 Pendulum Therapeutics
  • 13.15 BIOHM Health
  • 13.16 Seres Therapeutics, Inc.
  • 13.17 Ferring B.V.
  • 13.18 BiomeBank
  • 13.19 International Flavors & Fragrances Inc. (IFF)
  • 13.20 OptiBiotix Health Plc

List of Tables

  • Table 1 Global Gut Health and Microbiome Supplement Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Gut Health and Microbiome Supplement Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Gut Health and Microbiome Supplement Market Outlook, By Probiotics (2024-2032) ($MN)
  • Table 4 Global Gut Health and Microbiome Supplement Market Outlook, By Prebiotics (2024-2032) ($MN)
  • Table 5 Global Gut Health and Microbiome Supplement Market Outlook, By Synbiotics (2024-2032) ($MN)
  • Table 6 Global Gut Health and Microbiome Supplement Market Outlook, By Postbiotics (2024-2032) ($MN)
  • Table 7 Global Gut Health and Microbiome Supplement Market Outlook, By Enzymes (2024-2032) ($MN)
  • Table 8 Global Gut Health and Microbiome Supplement Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 9 Global Gut Health and Microbiome Supplement Market Outlook, By Ingredient (2024-2032) ($MN)
  • Table 10 Global Gut Health and Microbiome Supplement Market Outlook, By Bacteria (2024-2032) ($MN)
  • Table 11 Global Gut Health and Microbiome Supplement Market Outlook, By Yeast (2024-2032) ($MN)
  • Table 12 Global Gut Health and Microbiome Supplement Market Outlook, By Fibers (2024-2032) ($MN)
  • Table 13 Global Gut Health and Microbiome Supplement Market Outlook, By Formulation (2024-2032) ($MN)
  • Table 14 Global Gut Health and Microbiome Supplement Market Outlook, By Capsules & Tablets (2024-2032) ($MN)
  • Table 15 Global Gut Health and Microbiome Supplement Market Outlook, By Powder & Sachets (2024-2032) ($MN)
  • Table 16 Global Gut Health and Microbiome Supplement Market Outlook, By Liquids & Gummies (2024-2032) ($MN)
  • Table 17 Global Gut Health and Microbiome Supplement Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 18 Global Gut Health and Microbiome Supplement Market Outlook, By Hypermarkets/Supermarkets (2024-2032) ($MN)
  • Table 19 Global Gut Health and Microbiome Supplement Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 20 Global Gut Health and Microbiome Supplement Market Outlook, By Online Retail/E-commerce (2024-2032) ($MN)
  • Table 21 Global Gut Health and Microbiome Supplement Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 22 Global Gut Health and Microbiome Supplement Market Outlook, By Application (2024-2032) ($MN)
  • Table 23 Global Gut Health and Microbiome Supplement Market Outlook, By Digestive Health (2024-2032) ($MN)
  • Table 24 Global Gut Health and Microbiome Supplement Market Outlook, By Immune Support (2024-2032) ($MN)
  • Table 25 Global Gut Health and Microbiome Supplement Market Outlook, By Weight Management (2024-2032) ($MN)
  • Table 26 Global Gut Health and Microbiome Supplement Market Outlook, By Mental & Cognitive Health (2024-2032) ($MN)
  • Table 27 Global Gut Health and Microbiome Supplement Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 28 Global Gut Health and Microbiome Supplement Market Outlook, By End User (2024-2032) ($MN)
  • Table 29 Global Gut Health and Microbiome Supplement Market Outlook, By Adults (2024-2032) ($MN)
  • Table 30 Global Gut Health and Microbiome Supplement Market Outlook, By Children (2024-2032) ($MN)
  • Table 31 Global Gut Health and Microbiome Supplement Market Outlook, By Elderly (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.